MedTrace Logo

Multi-Omic, Clinomic and Digitomic Attributes of Major Depression for Integrative Analytics

NCT05910957 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-08-03

No results posted yet for this study

Summary

The purpose of this research is to see if information from blood and data from smartwatches can be combined to help diagnose depression and determine if transitions between active depression and treated depression can be predicted.

Conditions

Sponsors & Collaborators

  • Florida State University

    collaborator OTHER

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Mohit Chauhan, MBBS · Mayo Clinic

Eligibility

Min Age
20 Years
Max Age
62 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-02
Primary Completion
2026-06-06
Completion
2026-12-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05910957 on ClinicalTrials.gov